HOUSE_OVERSIGHT_024103.jpg

Sprout Capital VII, L.P. (Healthcare Technology Portfolio) $ amounts in millions, as of March 31, 2014 Please refer to Endnotes 1,],K,L,M and N in this Appendix. Gross Multiple Gross Vintage Total Realized Unrealize Total (Realized Multiple Company Sector Year Cost Value d Value Value Portion) (Total) Gross IRR All Investments Allos Therapeutics, Inc. herapeutics AviaHealth, Inc. (fka GoToMyDoc) Convergence 2000 2.0 0.0 - 0.0 0.02 0.02 -92.8% Cephalon, Inc. Therapeutics 1999 5.1 25.6 - 25.6 5.01 5.01 293.2% Charles River Laboratories Diagnostics & Infrastructure 1999 43 22.7 - 22.7 5.23 5:23 121.6% Deltagen, Inc. Therapeutics 1998 19.9 41 - 41 0.20 0.20 -30.3% eHealth, Inc. Convergence 1999 11.3 20.3 - 20.3 1.80 1.80 7.7% Gantech International, Inc. Therapeutics 1999 2.8 - - - - - NM Keravision Inc. Healthcare Devices 1998 10.2 - - - - - NM Microban International, Ltd. Diagnostics & Infrastructure 1999 14.8 39.7 - 39.7 2.68 2.68 14.5% Nuvelo, Inc. (fka Variagenics, Inc.) Therapeutics 1999 11.8 24.8 - 24.8 2.10 2.10 13.9% NxStage Medical, Inc. Healthcare Devices 1999 17.8 50.3 - 50.3 2.83 2.83 14.2% Phase Forward Incorporated Convergence 1998 9.0 38.6 - 38.6 4.31 4.31 22.4% SGX, Inc. Therapeutics 2000 15.0 1.6 - 1.6 0.11 0.11 -35.3% Skila, Inc. Convergence 1998 9.0 0.0 - 0.0 0.00 0.00 NM Spotfire, Inc. Convergence 1999 9.9 24.8 - 24.8 2.50 2.50 12.7% VascA, Inc. Healthcare Devices 1999 To 0.1 - 0.1 0.02 0.02 NM VNUS Medical Technologies, Inc. Healthcare Devices 1999 3.8 111 - 11.1 2.90 2.90 12.7% Total Sprout Capital VII, L.P. (HCT) Investments $ 157.5 $ 273.7 §$ - $ 273.7 1.74 1.74 10.1% 92 CONTROL NUMBER 257 - CONFIDENTIAL HOUSE_OVERSIGHT_024103